Alnylam Pharmaceuticals
ALNY
#581
Rank
C$49.71 B
Marketcap
$384.10
Share price
-0.94%
Change (1 day)
89.87%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

Alnylam Pharmaceuticals (ALNY) - Cost to borrow shares

Latest borrow fee for Alnylam Pharmaceuticals (ALNY) shares on Interactive Brokers: 0.3671% (annualized)

Shares available to borrow: 2000000

The cost to borrow / borrow fee is an annualized percentage an account is charged when borrowing shares of a stock.
Please note that the borrow fee and available shares to borrow displayed on this page are solely based on information provided by Interactive Brokers.

Alnylam Pharmaceuticals (ALNY) - cost to borrow in the last 7 days chart

Alnylam Pharmaceuticals (ALNY) - number of shares available to borrow in the last 7 days

Alnylam Pharmaceuticals (ALNY) - cost to borrow from 2025 to 2023

Alnylam Pharmaceuticals (ALNY) - number of shares available to borrow from 2025 to 2023

Cost to borrow for shares of similar companies or competitors

Company Cost to borrow (% year) Shares available Country
0.3971%1.7 M๐Ÿ‡บ๐Ÿ‡ธ USA
0.4081%1.7 M๐Ÿ‡บ๐Ÿ‡ธ USA
0.2723%1.6 M๐Ÿ‡บ๐Ÿ‡ธ USA
1.0707%0.45 M๐Ÿ‡บ๐Ÿ‡ธ USA
3.8721%0.1 M๐Ÿ‡บ๐Ÿ‡ธ USA
0.3069%1 M๐Ÿ‡จ๐Ÿ‡ญ Switzerland
0.25%1.8 M๐Ÿ‡ซ๐Ÿ‡ท France
0.4081%10 M๐Ÿ‡ฎ๐Ÿ‡ฑ Israel